<p>Karen Wu of Lucerna, Inc. in the U.S. seeks to develop a portable fluorescence-based device for the rapid detection of procalcitonin (PCT), a biomarker of early sepsis. An inexpensive, simple to use and highly durable device can aid in the early detection of neonatal sepsis, a major cause of infant mortality in developing countries.</p>


Karen Wu of Lucerna, Inc. in the U.S. seeks to develop a portable fluorescence-based device for the rapid detection of procalcitonin (PCT), a biomarker of early sepsis. An inexpensive, simple to use and highly durable device can aid in the early detection of neonatal sepsis, a major cause of infant mortality in developing countries.

Diagnostic Device for Early Detection of Neonatal Sepsis

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

.css-1nxq281{overflow:hidden;display:inline-block;}.css-1nxq281 span{display:inline-block;}Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

Great ideas come from everywhere.